|European Case Law Identifier:||ECLI:EP:BA:2009:T197408.20090217|
|Date of decision:||17 February 2009|
|Case number:||T 1974/08|
|IPC class:||A61K 31/202|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||Eicosapentaenoic acid (EPA) for treating anorexia nervosa (AN) and bulimia|
|Applicant name:||Amarin Neuroscience Limited|
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
I. The appeal contests the decision of the examining division dated 2 May 2008, refusing European patent application No. 03 750 919.7.
The appellant (applicant) filed a notice of appeal received on 11 July 2008 and paid the fee for appeal on the same day. No statement of grounds of appeal was filed.
II. In a communication dated 20 October 2008, sent by registered post with advice of delivery, the registrar of the board informed the appellant that no statement of grounds of appeal had been filed and that it was to be expected that it would be rejected as inadmissible. The appellant was informed about the possibility of filing a request for re-establishment of rights under Article 122 EPC and was invited to file observations within two months.
III. No reply was filed to said communication.
Reasons for the Decision
1. Article 108 EPC requires that a statement setting out the grounds of appeal shall be filed within four months of notification of the decision. Pursuant to Rule 101(1) EPC the appeal shall be rejected as inadmissible if it does not comply with Article 108 EPC.
2. In the present case no document was filed by the appellant which could be regarded as a statement setting out the grounds of appeal. Consequently the appeal has to be rejected as inadmissible.
For these reasons it is decided that:
The appeal is rejected as inadmissible.